search
Back to results

Evaluation of the Benefits of Adaptive Physical Activity in Children and Adolescents With Osteogenesis Imperfecta (MOVE-OI)

Primary Purpose

Osteogenesis Imperfecta

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Adapted sports practices
Sponsored by
Hospices Civils de Lyon
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Osteogenesis Imperfecta focused on measuring osteogenesis imperfecta, Adapted sport, Quality of life

Eligibility Criteria

6 Years - 17 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Child with osteogenesis imperfecta
  • Child followed in the Reference centre for constitutional bone diseases in the Hôpital Femme Mère Enfant
  • Parent (s) / legal guardian who has been informed of the study and has accepted participation in the study by signing the consent.
  • Patient benefiting from a social security scheme

Exclusion Criteria:

  • Medical and surgical contraindications to adapted physical activity.

Sites / Locations

  • Centre de Référence des Maladies Rénales Rares - Hospices Civils de Lyon - Service de Néphrologie et Rhumatologie Pédiatriques - Hôpital Femme Mère Enfant

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Adapted sports practice

Arm Description

patients with osteogenesis imperfect will practice adapted sport twice a week during 12 months in order to improve their aerobic capacity, cardiovascular and bone benefits, and gain of quality of life.

Outcomes

Primary Outcome Measures

6 minutes walk test
Distance traveled (in meters) in 6 minutes
6 minutes walk test
Distance traveled (in meters) in 6 minutes
6 minutes walk test
Distance traveled (in meters) in 6 minutes

Secondary Outcome Measures

Weight
weight in kilograms will be measured with a scale
Weight
weight in kilograms will be measured with a scale
Weight
weight in kilograms will be measured with a scale
Height
Size in meter measured with a meter
Height
Size in meter measured with a meter
Height
Size in meter measured with a meter
body mass index
calculated with weight and height
body mass index
calculated with weight and height
body mass index
calculated with weight and height
blood pressure
measurement of blood pressure (cm Hg)
blood pressure
measurement of blood pressure (cm Hg)
blood pressure
measurement of blood pressure (cm Hg)
phosphocalcic biologic parameters
Ionosodium (mmol/L)
phosphocalcic biologic parameters
potassium (mmol/L)
phosphocalcic biologic parameters
calcium (mmol/L)
phosphocalcic biologic parameters
chlore (mmol/L)
phosphocalcic biologic parameters
bicarbonates (mmol/L)
phosphocalcic biologic parameters
glucose (mmol/L)
phosphocalcic biologic parameters
urea (mmol/L)
phosphocalcic biologic parameters
creatinemia (mmol/L)
phosphocalcic biologic parameters
phosphorus (mmol/L)
phosphocalcic biologic parameters
proteinemia (g/L)
phosphocalcic biologic parameters
Vitamin D (nmol/L)
phosphocalcic biologic parameters
1-25 OH vitamin D (pmol/L)
phosphocalcic biologic parameters
PTH (ng/L)
phosphocalcic biologic parameters
alkaline bone phosphatases (U/L)
phosphocalcic biologic parameters
CTX (pg/ml)crosslaps
phosphocalcic biologic parameters
osteocalcin (µg/L)
phosphocalcic biologic parameters
ferritin (µg/L)
phosphocalcic biologic parameters
blood count formula : leucocytes (giga/L), erythrocytes (tera/L), hemoglobin (g/L), hematocrit (%), platelets (giga/L)
phosphocalcic biologic parameters
calciuria (mmol/L)
phosphocalcic biologic parameters
Ionosodium (mmol/L) potassium (mmol/L), calcium (mmol/L), chlore (mmol/L), bicarbonates (mmol/L), glucose (mmol/L), urea (mmol/L), creatinemia (mmol/L), phosphorus (mmol/L), proteinemia (g/L), Vitamin D (nmol/L), 1-25 OH vitamin D (pmol/L), PTH (ng/L), alkaline bone phosphatases (U/L), CTX (pg/ml)crosslaps, osteocalcin (µg/L), NFS, ferritin (µg/L), blood count formula : leucocytes (giga/L), erythrocytes (tera/L), hemoglobin (g/L), hematocrit (%), platelets (giga/L), calciuria (mmol/L), urinary creatinin (mmol/L).
ration lean mass / fat mass
Dual-energy X-ray absorptiometry (DXA)
ration lean mass / fat mass
Dual-energy X-ray absorptiometry (DXA)
Respiratory Functional Exploration
Respiratory Functional Exploration
Thickness intima / media
echography
Parameters of the connected watch : number of steps
data recovery of the connected watch
Parameters of the connected watch : distance traveled
data recovery of the connected watch
Parameters of the connected watch : calories consumption
data recovery of the connected watch
Ratio thickness intima / media
echography
Bone mineral density
Dual-energy X-ray absorptiometry (DXA)
Bone mineral density
Dual-energy X-ray absorptiometry (DXA)
Number of new fractures
Number of new fractures
Number of new fractures
Number of new fractures
Number of new fractures
Quality of life questionnaire : PedsQL
Measurement Model for the Pedratric Quality of Life Inventory The 4 Multidimensional Scales and 3 Summary Scores are Scales Physical Functioning (8 items) Emotional Functioning (5 items) Social Functioning (5 items) School Functioning (5 items) Summary Scores Total Scale Score (23 items) Physical Health Summary Score (8 items) Psychosocial Health Summary Score (15 items)
Quality of life questionnaire : PedsQL
Measurement Model for the Pedratric Quality of Life Inventory The 4 Multidimensional Scales and 3 Summary Scores are Scales Physical Functioning (8 items) Emotional Functioning (5 items) Social Functioning (5 items) School Functioning (5 items) Summary Scores Total Scale Score (23 items) Physical Health Summary Score (8 items) Psychosocial Health Summary Score (15 items)
Quality of life questionnaire : PedsQL
Measurement Model for the Pedratric Quality of Life Inventory The 4 Multidimensional Scales and 3 Summary Scores are Scales Physical Functioning (8 items) Emotional Functioning (5 items) Social Functioning (5 items) School Functioning (5 items) Summary Scores Total Scale Score (23 items) Physical Health Summary Score (8 items) Psychosocial Health Summary Score (15 items)

Full Information

First Posted
October 1, 2019
Last Updated
January 25, 2023
Sponsor
Hospices Civils de Lyon
search

1. Study Identification

Unique Protocol Identification Number
NCT04119388
Brief Title
Evaluation of the Benefits of Adaptive Physical Activity in Children and Adolescents With Osteogenesis Imperfecta
Acronym
MOVE-OI
Official Title
Evaluation of the Benefits of Adaptive Physical Activity in Children and Adolescents With Osteogenesis Imperfecta
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Completed
Study Start Date
November 4, 2019 (Actual)
Primary Completion Date
October 14, 2022 (Actual)
Study Completion Date
October 14, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospices Civils de Lyon

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Osteogenesis imperfecta (OI) is a rare genetic disorder of increased bone fragility and low bone mass. It is conceivable that children and adolescents with OI are less active than healthy peers because of frequent fractures, immobilization,functionals limitations and no adapted physicals activity(APA). The hypothesis is that an Adapted physique activity could improve access of activity for patients with Osteogenesis Imperfecta (OI). The aim of the study is to evaluate benefice of APA,improve aerobic capacity, cardiovascular and bone benefits, and gain of quality of life. Children with OI between 6 and 18 years old will have a program of supervised "adapted training program" during one year. The program is adapted at each individual and without risk for the patient.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteogenesis Imperfecta
Keywords
osteogenesis imperfecta, Adapted sport, Quality of life

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
30 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Adapted sports practice
Arm Type
Experimental
Arm Description
patients with osteogenesis imperfect will practice adapted sport twice a week during 12 months in order to improve their aerobic capacity, cardiovascular and bone benefits, and gain of quality of life.
Intervention Type
Other
Intervention Name(s)
Adapted sports practices
Intervention Description
Adapted sports practices for 30 minutes twice a week
Primary Outcome Measure Information:
Title
6 minutes walk test
Description
Distance traveled (in meters) in 6 minutes
Time Frame
Month 0
Title
6 minutes walk test
Description
Distance traveled (in meters) in 6 minutes
Time Frame
Month 6
Title
6 minutes walk test
Description
Distance traveled (in meters) in 6 minutes
Time Frame
Month 12
Secondary Outcome Measure Information:
Title
Weight
Description
weight in kilograms will be measured with a scale
Time Frame
Month 0
Title
Weight
Description
weight in kilograms will be measured with a scale
Time Frame
Month 6
Title
Weight
Description
weight in kilograms will be measured with a scale
Time Frame
Month 12
Title
Height
Description
Size in meter measured with a meter
Time Frame
Month 0
Title
Height
Description
Size in meter measured with a meter
Time Frame
Month 6
Title
Height
Description
Size in meter measured with a meter
Time Frame
Month 12
Title
body mass index
Description
calculated with weight and height
Time Frame
Month 0
Title
body mass index
Description
calculated with weight and height
Time Frame
Month 6
Title
body mass index
Description
calculated with weight and height
Time Frame
Month 12
Title
blood pressure
Description
measurement of blood pressure (cm Hg)
Time Frame
Month 0
Title
blood pressure
Description
measurement of blood pressure (cm Hg)
Time Frame
Month 6
Title
blood pressure
Description
measurement of blood pressure (cm Hg)
Time Frame
Month 12
Title
phosphocalcic biologic parameters
Description
Ionosodium (mmol/L)
Time Frame
Month 0 and Month 12
Title
phosphocalcic biologic parameters
Description
potassium (mmol/L)
Time Frame
Month 0 and Month 12
Title
phosphocalcic biologic parameters
Description
calcium (mmol/L)
Time Frame
Month 0 and Month 12
Title
phosphocalcic biologic parameters
Description
chlore (mmol/L)
Time Frame
Month 0 and Month 12
Title
phosphocalcic biologic parameters
Description
bicarbonates (mmol/L)
Time Frame
Month 0 and Month 12
Title
phosphocalcic biologic parameters
Description
glucose (mmol/L)
Time Frame
Month 0 and Month 12
Title
phosphocalcic biologic parameters
Description
urea (mmol/L)
Time Frame
Month 0 and Month 12
Title
phosphocalcic biologic parameters
Description
creatinemia (mmol/L)
Time Frame
Month 0 and Month 12
Title
phosphocalcic biologic parameters
Description
phosphorus (mmol/L)
Time Frame
Month 0 and Month 12
Title
phosphocalcic biologic parameters
Description
proteinemia (g/L)
Time Frame
Month 0 and Month 12
Title
phosphocalcic biologic parameters
Description
Vitamin D (nmol/L)
Time Frame
Month 0 and Month 12
Title
phosphocalcic biologic parameters
Description
1-25 OH vitamin D (pmol/L)
Time Frame
Month 0 and Month 12
Title
phosphocalcic biologic parameters
Description
PTH (ng/L)
Time Frame
Month 0 and Month 12
Title
phosphocalcic biologic parameters
Description
alkaline bone phosphatases (U/L)
Time Frame
Month 0 and Month 12
Title
phosphocalcic biologic parameters
Description
CTX (pg/ml)crosslaps
Time Frame
Month 0 and Month 12
Title
phosphocalcic biologic parameters
Description
osteocalcin (µg/L)
Time Frame
Month 0 and Month 12
Title
phosphocalcic biologic parameters
Description
ferritin (µg/L)
Time Frame
Month 0 and Month 12
Title
phosphocalcic biologic parameters
Description
blood count formula : leucocytes (giga/L), erythrocytes (tera/L), hemoglobin (g/L), hematocrit (%), platelets (giga/L)
Time Frame
Month 0 and Month 12
Title
phosphocalcic biologic parameters
Description
calciuria (mmol/L)
Time Frame
Month 0 and Month 12
Title
phosphocalcic biologic parameters
Description
Ionosodium (mmol/L) potassium (mmol/L), calcium (mmol/L), chlore (mmol/L), bicarbonates (mmol/L), glucose (mmol/L), urea (mmol/L), creatinemia (mmol/L), phosphorus (mmol/L), proteinemia (g/L), Vitamin D (nmol/L), 1-25 OH vitamin D (pmol/L), PTH (ng/L), alkaline bone phosphatases (U/L), CTX (pg/ml)crosslaps, osteocalcin (µg/L), NFS, ferritin (µg/L), blood count formula : leucocytes (giga/L), erythrocytes (tera/L), hemoglobin (g/L), hematocrit (%), platelets (giga/L), calciuria (mmol/L), urinary creatinin (mmol/L).
Time Frame
Month 0 and Month 12
Title
ration lean mass / fat mass
Description
Dual-energy X-ray absorptiometry (DXA)
Time Frame
Month 0
Title
ration lean mass / fat mass
Description
Dual-energy X-ray absorptiometry (DXA)
Time Frame
Month 12
Title
Respiratory Functional Exploration
Time Frame
Month 0
Title
Respiratory Functional Exploration
Time Frame
Month 12
Title
Thickness intima / media
Description
echography
Time Frame
Month 0
Title
Parameters of the connected watch : number of steps
Description
data recovery of the connected watch
Time Frame
Month 0 and Month 6 and Month 12
Title
Parameters of the connected watch : distance traveled
Description
data recovery of the connected watch
Time Frame
Month 0 and Month 6 and Month 12
Title
Parameters of the connected watch : calories consumption
Description
data recovery of the connected watch
Time Frame
Month 0 and Month 6 and Month 12
Title
Ratio thickness intima / media
Description
echography
Time Frame
Month 12
Title
Bone mineral density
Description
Dual-energy X-ray absorptiometry (DXA)
Time Frame
Month 0
Title
Bone mineral density
Description
Dual-energy X-ray absorptiometry (DXA)
Time Frame
Month 12
Title
Number of new fractures
Time Frame
Month 1
Title
Number of new fractures
Time Frame
Month 3
Title
Number of new fractures
Time Frame
Month 6
Title
Number of new fractures
Time Frame
Month 9
Title
Number of new fractures
Time Frame
Month 12
Title
Quality of life questionnaire : PedsQL
Description
Measurement Model for the Pedratric Quality of Life Inventory The 4 Multidimensional Scales and 3 Summary Scores are Scales Physical Functioning (8 items) Emotional Functioning (5 items) Social Functioning (5 items) School Functioning (5 items) Summary Scores Total Scale Score (23 items) Physical Health Summary Score (8 items) Psychosocial Health Summary Score (15 items)
Time Frame
Month 0
Title
Quality of life questionnaire : PedsQL
Description
Measurement Model for the Pedratric Quality of Life Inventory The 4 Multidimensional Scales and 3 Summary Scores are Scales Physical Functioning (8 items) Emotional Functioning (5 items) Social Functioning (5 items) School Functioning (5 items) Summary Scores Total Scale Score (23 items) Physical Health Summary Score (8 items) Psychosocial Health Summary Score (15 items)
Time Frame
Month 6
Title
Quality of life questionnaire : PedsQL
Description
Measurement Model for the Pedratric Quality of Life Inventory The 4 Multidimensional Scales and 3 Summary Scores are Scales Physical Functioning (8 items) Emotional Functioning (5 items) Social Functioning (5 items) School Functioning (5 items) Summary Scores Total Scale Score (23 items) Physical Health Summary Score (8 items) Psychosocial Health Summary Score (15 items)
Time Frame
Month 12

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Child with osteogenesis imperfecta Child followed in the Reference centre for constitutional bone diseases in the Hôpital Femme Mère Enfant Parent (s) / legal guardian who has been informed of the study and has accepted participation in the study by signing the consent. Patient benefiting from a social security scheme Exclusion Criteria: Medical and surgical contraindications to adapted physical activity.
Facility Information:
Facility Name
Centre de Référence des Maladies Rénales Rares - Hospices Civils de Lyon - Service de Néphrologie et Rhumatologie Pédiatriques - Hôpital Femme Mère Enfant
City
Bron
ZIP/Postal Code
69500
Country
France

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Evaluation of the Benefits of Adaptive Physical Activity in Children and Adolescents With Osteogenesis Imperfecta

We'll reach out to this number within 24 hrs